Notices. Notice of retraction of a new system of records
2,043 words·~9 min read·
/register/2007/07/30/07-3681A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4160-90-M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services Privacy Act of 1974; Retraction of a New System of Records AGENCY: Department of Health and Human Services (HHS), Centers for Medicare & Medicaid Services (CMS). ACTION: Notice of retraction of a new system of records. SUMMARY: The Centers for Medicare & Medicaid Services CMS inadvertently published a new system of records titled “Post Acute Care Payment Reform/Continuity of Assessment Report and Evaluation Demonstration and Evaluation (PAC-CARE)” System No. 09-70-0569 in the **Federal Register**
(FR)on Thursday, April 19, 2007 (72 FR 19711). CMS is withdrawing the notice due to comments received that a routine use disclosure provision necessary to carry out essential parts of the demonstration project was inadvertently omitted. The notice of a new system of records will be republished at a later date with the routine use included. FOR FURTHER INFORMATION CONTACT: Inquiries may be directed to: CMS Privacy Officer, Division of Privacy Compliance, Enterprise Architecture and Strategy Group, Office of Information Services, CMS, Room N2-04-27, 7500 Security Boulevard, Baltimore, Maryland 21244-1850. He can also be reached at 410-786-5357 or by e-mail at *walter.stone@cms.hhs.gov.* Dated: July 18, 2007. William Saunders, Acting Deputy Director, Office of Information Services, Centers for Medicare & Medicaid Services. [FR Doc. E7-14631 Filed 7-27-07; 8:45 am] BILLING CODE 4120-03-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Assuring Radiation Protection; Cooperative Agreement; Request for Applications: RFA-FDA-CDRH-07-004; Catalog of Federal Domestic Assistance Number: 93.103 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. I. Funding Opportunity Description The Food and Drug Administration
(FDA)is announcing its intention to receive and consider applications for the award of a cooperative agreement in fiscal year 2007
(FY07)to provide support in furtherance of FDA's responsibilities, under section 532 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ii), to establish and carry out a comprehensive radiation control program. An estimated amount of support in FY07 will be for up to $400,000, with an additional 5 years of support, subject to the condition that in addition to FDA funds, augmenting funds are transferred to FDA from other Federal agencies to fully support this program. Funds may not be used to fund or conduct international activities or initiatives. As the lead Federal agency, FDA intends to collect funds from all other contributing Federal agencies through Interagency Agreements and fund one award for up to $400,000 in total costs (including both direct and indirect costs). After the first year, additional years of noncompetitive support are predicated upon acceptable performance during the preceding year and the availability of Federal funds. The cooperative agreement will allow FDA to continue to work with the Nuclear Regulatory Commission and its predecessor organizations, the Environmental Protection Agency and the Federal Emergency Management Agency, to provide financial support for a forum established to foster the exchange of ideas and information among the States and the Federal Government concerning radiation control. This forum has made it possible for State and Federal agencies to work together to study existing and potential radiological health problems of mutual interest and to apply their increasingly limited resources with maximum efficiency in seeking ways to address these problems, fostering coordination, and providing original views. II. Award Information The objective of this cooperative agreement is to coordinate Federal, State, and Tribal activities to achieve effective solutions to present and future radiation control problems. The recipient of this cooperative agreement award will be expected to obtain the States' cooperation and participation on committees and working groups established to deal with individual problems. The recipient will also plan and facilitate an annual meeting, and develop and offer educational activities to demonstrate mutually beneficial techniques, procedures, and systems relevant to the mission of assuring radiation protection. The recipient will establish committees to address, evaluate, and offer solutions for a wide range of radiation health and protection issues. Examples of relevant areas of interest include, but are not limited to:
(1)The application of x-rays to the healing arts,
(2)the application of medical/nonmedical ionizing radiation, and
(3)the control and mitigation of radiation exposure from all sources. *Copyright Material* : Applicants and applicants' subgrantees and subcontractors must ensure that any projects developed in whole or in part with Federal funds will be made available to other State, territorial, local, and tribal agencies by FDA or its agents. Any copyrighted or copyrightable works shall be subject to a royalty-free, nonexclusive, and irrevocable license to the Federal Government to reproduce, publish, or otherwise use them, and to authorize others to do so for Federal Government purposes. III. Eligibility Information This cooperative agreement is available to any domestic private or public nonprofit organization (including State and local units of government) and to any domestic for-profit organization. For-profit organizations must exclude fees or profit from their requested support. Organizations described in section 501(c)(4) of the Internal Revenue Code of 1968 that engage in lobbying are not eligible to receive awards. IV. Submission Information/Requirements Applications for this program must be made electronically. To apply, applicants should visit *http://www.grants.gov* 1 and follow the instructions under “Apply for Grants.” The required application, SF424 (Research & Related) (also referred to as the “SF424 (R&R)”), can be completed and submitted online. The package should be labeled “Response to FDA RFA number is FD07-004”. If you experience technical difficulties with your online submission, you should contact the Grants.gov Customer Response Center. Information about submitting an application electronically can be found at *http://www.grants.gov* . In order to apply electronically, the applicant must have a DUNS number and register in the Central Contractor Registration
(CCR)database. In addition, applicants will be required to register with the Credential Provider. Information about this is available at *http://apply.grants.gov/OrcRegister* , 1 or by calling ORC's help desk at 800-816-5548. 1 (FDA has verified the Web site address, but FDA is not responsible for any subsequent changes to the Web site after this document publishes in the **Federal Register** .) *Dun and Bradstreet Number (DUNS)* : As of October 1, 2003, applicants are required to have a DUNS number to apply for a grant or cooperative agreement from the Federal Government. The DUNS number is a 9-digit identification number that uniquely identifies business entities. Obtaining a DUNS number is easy and there is no charge. To obtain a DUNS number, call Dun and Bradstreet at 1-866-705-5711 and identify yourself as a Federal grant applicant. *Central Contractor Registration* : Applicants must also register in the Central Contractor Registration
(CCR)database. Applicants must have a DUNS number to begin registration in the CCR database. The CCR is a database is a government wide repository of commercial and financial information for all organizations conducting business with the Federal Government. Registration with CCR will eventually become a requirement for grant applicants and is consistent with the government wide management reform to create a citizen-centered Web presence and build e-gov infrastructures in and across agencies to establish a “single face to industry.” The preferred method for completing registration is on the Internet at *http://www.ccr.gov* . 1 This Web site provides a CCR handbook with detailed information on data that applicants will need prior to beginning the online registration, as well as steps to walk applicants through the registration process. Additional information concerning the application process for this cooperative agreement can be found on FDA's Web site ( *http://www.fda.gov/cdrh* ) and also through the Grants.gov Web site ( *http://www.grants.gov* ). *Submission Date* : The application receipt date August 14, 2007. No supplemental or addendum material will be accepted after the receipt date. V. Agency Contacts For additional information regarding the administrative and financial management aspects of this notice, contact Gladys M. Bohler, Food and Drug Administration (HFA-500), 5630 Fishers Lane, Rm. 2105, Rockville, MD 20857; 301-827-7168, FAX: 301-827-7101; e-mail: *gladys.melendez-bohler@fda.hhs.gov* . For additional information regarding the programmatic aspects of this notice, contact Sara Sutphin, Center for Devices and Radiological Health (HFZ-205), Food and Drug Administration, 1350 Piccard Dr., Rockville, MD 20850; 240-276-3225, FAX: 240-276-3201; e-mail: *Sara.Sutphin@fda.hhs.gov* . Dated: July 23, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7-14610 Filed 7-27-07; 8:45 am] BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed collection; Comment Request; Physicians' Experience of Ethical Dilemmas and Resource Allocation SUMMARY: In accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104-13) and Office of Management and Budget
(OMB)regulations at 5 CFR Part 1320 (60 FR 44978, August 29, 1995), this notice announces the intention of the Department of Bioethics, National Institutes of Health (NIHDCB) to request approval for a new information collection, Physicians' Experience of Ethical Dilemmas and Resource Allocation. The proposed information collection was previously published in the **Federal Register** on May 17, 2007, on pages 27817-18 and allowed 60-days for public comment. Two public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. *Proposed Collection: Title:* Physicians' Experience of Ethical Dilemmas and Resource Allocation. *Type of Information Collection Request:* New. *Need and Use of Information Collection:* Health care costs are rising ceaselessly and there are currently no generally accepted way of controlling them. This study will access the experience of physicians regarding resource allocation in clinical practice, and how allocation decisions made at other levels shapes this experience. The primary objectives of the study are to determine if physicians make decisions to withhold interventions on the basis of cost, how often they report doing so, what types of care are withheld, and what criteria are used in making such decisions. The findings will provide valuable information concerning:
(1)The practice of resource allocation in clinical practice,
(2)the possible effects of perceived constraints on this practice; and
(3)international comparisons on these two aspects. *Frequency of Response:* Once. *Affected Public:* Individuals or households; Businesses or other for-profit; Not-for-profit institutions. *Type of Respondents:* Physicians. The annual reporting burden is as follows: *Estimated Number of Respondents:* 250; Estimated *Number of Responses per Respondent: 1; Average Burden Hours per Response:* 0.3674; and Estimated *Total Annual Burden Hours Requested:* 91.85. The annualized cost to respondents is estimated at: $5,218. There are no Capital Costs, Operating Costs and/or Maintenance Costs to report. *Request for Comments:* Written comments and/or suggestions from the public and affected agencies should address one or more of the following points:
(1)Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility;
(2)Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
(3)Enhance the quality, utility, and clarity of the information to be collected; and
(4)Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. *Direct Comments to OMB:* Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, New Executive Office Building, Room 10235, Washington, DC 20503, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Dr. Marion Danis, Department of Bioethics, DCB, CC, NIH, Building 10, Room 1C 118, 9000 Rockville Pike, Bethesda, MD 20892-1156, or call non-toll-free number 301-435-8727 or e-mail your request, including your address to: *mdanis@cc.nih.gov.* *Comments Due Date:* Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. Dated: July 24, 2007. David K. Henderson, Deputy Director, Warren G. Magnuson Clinical Center, National Institutes of Health. Rebecca Chen, Senior Department Administrator, Department of Clinical Bioethics, Warren G. Magnuson Clinical Center, National Institutes of Health. [FR Doc. 07-3681 Filed 7-27-07; 8:45 am]
Connectionstraces to 1
Traces to 1 document
U.S. Code
2 references not yet in our index
- Pub. L. 104-13
- 5 CFR 1320
Citation graph
cites case law
Notices
Notice of retraction of a new system of records
Pub. L.Pub. L. 104-13
Cite5 CFR 1320
Cites 3Cited by 0 across 0 sources